Attached files

file filename
EX-10.23 - MB CASH CONTRIBUTION AGREEMENT - Endo International plcex1023mbcashcontributi.htm
EX-32.2 - CFO 906 CERT - Endo International plcex32212312019cfo906cert.htm
EX-32.1 - CEO 906 CERT - Endo International plcex32112312019ceo906cert.htm
EX-31.2 - CFO 302 CERT - Endo International plcex31212312019cfo302cert.htm
EX-31.1 - CEO 302 CERT - Endo International plcex31112312019ceo302cert.htm
EX-24.1 - POWER OF ATTORNEY - Endo International plcex24112312019powerofat.htm
EX-21.1 - 12.31.2019 SUBSIDIARIES - Endo International plcex21112312019subsidiar.htm
EX-10.24 - MB LETTER AGREEMENT - Endo International plcex1024mbletteragreement.htm
EX-10.19 - CFO AGREEMENT - Endo International plca1019cfoagreement.htm
EX-10.18.1 - CEO AGREEMENT - Endo International plca10181ceoagreement.htm
EX-4.1 - DESCRIPTION OF SECURITIES - Endo International plcex41descriptionofregis.htm
10-K - 10-K - Endo International plcendp-12312019x10k.htm
Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-194253, No. 333-204958, No. 333-219806, No. 333-226677 and No. 333-233029) and Form S-3 (No. 333-226676) of Endo International plc of our report dated February 26, 2020 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.


/s/ PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania
February 26, 2020